Knappertz Volker — SEC Form 4 filings
SEC reporting owner CIK 1754122. 2 Form 4 filings on record with FilingPulse; latest filed 2024-02-29.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2024-02-22 to 2024-02-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 30,076 shares, $167,873 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 25,146 shares @ $5.48 ($137,800) in Aurinia Pharmaceuticals Inc., filed 2024-02-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | EVP, Research and Development | 2 | — | 2 legs · 30,076 sh · $167,873 | — |
Form 4 filings — Knappertz Volker
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-29 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 4,930 @ $6.10 | EDGAR |
| 2024-02-22 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 25,146 @ $5.48 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1754122 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →